Mphahlele, M.J.; Agbo, E.N.; More, G.K.; Gildenhuys, S.
In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties. Antioxidants 2021, 10, 647.
https://doi.org/10.3390/antiox10050647
AMA Style
Mphahlele MJ, Agbo EN, More GK, Gildenhuys S.
In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties. Antioxidants. 2021; 10(5):647.
https://doi.org/10.3390/antiox10050647
Chicago/Turabian Style
Mphahlele, Malose J., Emmanuel N. Agbo, Garland K. More, and Samantha Gildenhuys.
2021. "In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties" Antioxidants 10, no. 5: 647.
https://doi.org/10.3390/antiox10050647
APA Style
Mphahlele, M. J., Agbo, E. N., More, G. K., & Gildenhuys, S.
(2021). In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties. Antioxidants, 10(5), 647.
https://doi.org/10.3390/antiox10050647